StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Connect Biopharma's EPS for the twelve months ending Jun 30, 2026 was -$1.19. For fiscal 2025 it was -$1.00. The highest annual figure on record is -$0.28 in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.00–
FY2024Dec 31, 2024-$0.28–
FY2023Dec 31, 2023-$1.13–
FY2022Dec 31, 2022-$2.15–
FY2021Dec 31, 2021-$3.88–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.27–
Q1 FY2026Mar 31, 2026-$0.34–
Q4 FY2025Dec 31, 2025-$0.27–
Q3 FY2025Sep 30, 2025-$0.31–
Q2 FY2025Jun 30, 2025-$0.23-185.2%
Q1 FY2025Mar 31, 2025-$0.19–
Q4 FY2024Dec 31, 2024-$0.16–
Q3 FY2024Sep 30, 2024-$0.23–
Q2 FY2024Jun 30, 2024$0.27–
Q1 FY2024Mar 31, 2024-$0.16–

More Connect Biopharma figures

See a number that looks wrong?